{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:40:06Z","timestamp":1792788006320,"version":"4.5.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T00:00:00Z","timestamp":1713312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T00:00:00Z","timestamp":1713312000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Disciplinary Construction Project of Minhang Hospital, Shanghai","award":["YJXK-2021-08"],"award-info":[{"award-number":["YJXK-2021-08"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Most colorectal cancers originate from precancerous polyps. This study aimed to determine the prevalence of colorectal polyps with diverse pathological morphologies and to explore the risk factors for colorectal carcinoma in situ (CCS) and neoplastic polyps.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Inpatients admitted from January 2018 to May 2023 were screened through the hospital information system. Polyps were classified according to pathological morphology. The prevalence of polyps was described by frequency and 95% confidence interval. Univariate and multivariate logistic regression analyses were used to explore the risk factors for CCS and neoplastic polyps.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In total, 2329 individuals with 3550 polyps were recruited. Among all patients, 76.99% had neoplastic polyps and 44.31% had advanced adenomas. Tubular adenoma had the highest prevalence at 60.15%, and the prevalence of CCS was 3.86%. Patients with a colorectal polyp diameter\u2009\u2265\u20091.0\u00a0cm or number\u2009\u2265\u20093 were 8.07 times or 1.98 times more likely to develop CCS than were those with a diameter\u2009&lt;\u20091.0\u00a0cm or number\u2009&lt;\u20093, respectively (OR 8.07, 95%CI 4.48\u201314.55,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001; and OR 1.98, 95%CI 1.27\u20133.09,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.002). The risk of CCS with schistosome egg deposition was also significantly increased (OR 2.70, 95%CI 1.05\u20136.98). The higher the levels of carbohydrate antigen (CA)\u00a0724 (OR 1.01, 95%CI 1.00\u20131.02) and CA211 (OR 1.16, 95%CI 1.03\u20131.32) in patients with colorectal polyps were, the greater the risk of CCS. When colorectal neoplastic polyps were analyzed, we discovered that for each 1-year increase in age, the risk of neoplastic polyps increased by 3% (OR 1.03, 95%CI 1.02\u20131.04),\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001. Patients with a polyp diameter\u2009\u2265\u20091.0\u00a0cm had a 2.11-fold greater risk of neoplastic polyps compared to diameter\u2009&lt;\u20091.0\u00a0cm patients (OR 3.11, 95%CI 2.48\u20133.92),\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001. In addition, multiple polyps and CA199 levels are risk factors for neoplastic polyps.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>More than 3\/4 of colorectal polyp patients have neoplastic polyps. Patients are more inclined to develop CCS and neoplastic polyps if they have large polyps (&gt;\u20091.0\u00a0cm) or multifocal polyps. The levels of the tumor markers CA724 and CA211 show some potential usefulness for predicting CCS and may be exploited for early identification of high-risk populations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12967-024-05111-z","type":"journal-article","created":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T04:29:24Z","timestamp":1713328164000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Prevalence of diverse colorectal polyps and risk factors for colorectal carcinoma in situ and neoplastic polyps"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6975-3268","authenticated-orcid":false,"given":"Xiaojuan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengting","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,17]]},"reference":[{"issue":"3","key":"5111_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H SUNG","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"5111_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W CHEN","year":"2016","unstructured":"Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015 [J]. CA Cancer J Clin. 2016;66(2):115\u201332.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"5111_CR3","first-page":"291","volume":"158","author":"A NGUYEN L H, GOEL","year":"2020","unstructured":"Nguyen LH, Goel A, Chung DC. Pathways Colorectal Carcinog [J] Gastroenterol. 2020;158(2):291\u2013302.","journal-title":"Pathways Colorectal Carcinog [J] Gastroenterol"},{"issue":"1","key":"5111_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0889-8553(05)70280-6","volume":"26","author":"KIM E C","year":"1997","unstructured":"Kim E C. Colorectal polyps and their relationship to cancer [J]. Gastroenterol Clin North Am. 1997;26(1):1\u201317.","journal-title":"Gastroenterol Clin North Am"},{"issue":"5","key":"5111_CR5","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1053\/j.gastro.2020.08.050","volume":"159","author":"A SHAUKAT","year":"2020","unstructured":"Shaukat A, Kaltenbach T, Dominitz JA, et al. Endoscopic recognition and management strategies for malignant colorectal polyps: recommendations of the US Multi-society Task Force on Colorectal Cancer [J]. Gastroenterology. 2020;159(5):1916\u2013e342.","journal-title":"Gastroenterology"},{"issue":"2","key":"5111_CR6","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3322\/canjclin.47.2.93","volume":"47","author":"MARKOWITZ A J","year":"1997","unstructured":"Markowitz AJ, Winawer SJ. Management of colorectal polyps [J]. CA Cancer J Clin. 1997;47(2):93\u2013112.","journal-title":"CA Cancer J Clin"},{"key":"5111_CR7","doi-asserted-by":"crossref","unstructured":"Bech JM, Terkelsen T, Bartels AS et al. Proteomic profiling of colorectal adenomas identifies a predictive risk signature for development of metachronous advanced colorectal neoplasia [J]. Gastroenterology, 2023.","DOI":"10.1053\/j.gastro.2023.03.208"},{"issue":"6","key":"5111_CR8","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S2468-1253(20)30009-1","volume":"5","author":"M SONG","year":"2020","unstructured":"Song M, Emilsson L, Bozorg S R, et al. Risk of colorectal cancer incidence and mortality after polypectomy: a Swedish record-linkage study [J]. Lancet Gastroenterol Hepatol. 2020;5(6):537\u201347.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"5111_CR9","doi-asserted-by":"crossref","unstructured":"Meester RGS, Van Herk M, Lansdorp-Vogelaar I et al. Prevalence and clinical features of Sessile Serrated polyps: a systematic review [J]. Gastroenterology, 2020, 159(1): 105\u2009\u2013\u200918.e25.","DOI":"10.1053\/j.gastro.2020.03.025"},{"issue":"4","key":"5111_CR10","doi-asserted-by":"publisher","first-page":"399","DOI":"10.5009\/gnl19097","volume":"14","author":"Y HAO","year":"2020","unstructured":"Hao Y, Wang Y, Qi M, et al. Risk factors for recurrent colorectal polyps [J]. Gut Liver. 2020;14(4):399\u2013411.","journal-title":"Gut Liver"},{"key":"5111_CR11","unstructured":"Bosman FT, Carneiro F, Hruban, RH, Theise, ND. WHO Classification of Tumours of the Digestive System. [J]. 2010, 4th ed. IARC, Lyon 2010: 131\u2009\u2013\u200946."},{"issue":"3","key":"5111_CR12","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1055\/s-2002-20296","volume":"34","author":"A RUBIO C","year":"2002","unstructured":"Rubio CA, Jaramillo E, Lindblom A, et al. Classification of colorectal polyps: guidelines for the endoscopist [J]. Endoscopy. 2002;34(3):226\u201336.","journal-title":"Endoscopy"},{"key":"5111_CR13","doi-asserted-by":"crossref","unstructured":"He X, Hang D, Wu K et al. Long-term risk of Colorectal Cancer after removal of conventional adenomas and serrated polyps [J]. Gastroenterology, 2020, 158(4): 852\u2009\u2013\u200961.e4.","DOI":"10.1053\/j.gastro.2019.06.039"},{"issue":"2","key":"5111_CR14","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.cgh.2008.08.031","volume":"7","author":"LAIYEMO","year":"2009","unstructured":"Laiyemo AO, Murphy G, Sansbury LB, et al. Hyperplastic polyps and the risk of adenoma recurrence in the polyp prevention trial [J]. Clin Gastroenterol Hepatol. 2009;7(2):192\u20137.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"5111_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41572-018-0013-8","volume":"4","author":"M MCMANUS D P, DUNNE D W, SACKO","year":"2018","unstructured":"Mcmanus DP, Dunne DW, Sacko M, et al. Schistosomiasis [J]. Nat Rev Dis Primers. 2018;4(1):13.","journal-title":"Nat Rev Dis Primers"},{"key":"5111_CR16","doi-asserted-by":"crossref","unstructured":"Kim J, Nath K, Schmidlin K et al. Hierarchical contribution of individual lifestyle factors and their interactions on adenomatous and serrated polyp risk [J]. J Gastroenterol, 2023.","DOI":"10.1007\/s00535-023-02004-8"},{"issue":"7","key":"5111_CR17","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1016\/j.cgh.2022.10.003","volume":"21","author":"S GUPTA","year":"2023","unstructured":"Gupta S, Earles A, Bustamante R, et al. Adenoma Detection Rate and clinical characteristics Influence Advanced Neoplasia Risk after Colorectal polypectomy [J]. Clin Gastroenterol Hepatol. 2023;21(7):1924\u2013e369.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"5111_CR18","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1084\/jem.122.3.467","volume":"122","author":"P GOLD","year":"1965","unstructured":"Gold P, Freedman SO. Specific carcinoembryonic antigens of the human digestive system [J]. J Exp Med. 1965;122(3):467\u201381.","journal-title":"J Exp Med"},{"issue":"4","key":"5111_CR19","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1093\/clinchem\/47.4.624","volume":"47","author":"MJ DUFFY","year":"2001","unstructured":"Duffy MJ. Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful? [J]. Clin Chem. 2001;47(4):624\u201330.","journal-title":"Clin Chem"},{"issue":"6","key":"5111_CR20","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/S0959-8049(02)00811-0","volume":"39","author":"MJ DUFFY","year":"2003","unstructured":"Duffy MJ, Van Dalen A, Haglund C, et al. Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour markers (EGTM) guidelines [J]. Eur J Cancer. 2003;39(6):718\u201327.","journal-title":"Eur J Cancer"},{"issue":"22","key":"5111_CR21","first-page":"5293","volume":"56","author":"F GUADAGNI","year":"1996","unstructured":"Guadagni F, Roselli M, Cosimelli M, et al. Correlation between tumor-associated glycoprotein 72 mucin levels in tumor and serum of colorectal patients as measured by the quantitative CA 72\u2009\u2013\u20094 immunoassay [J]. Cancer Res. 1996;56(22):5293\u20138.","journal-title":"Cancer Res"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05111-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-024-05111-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05111-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T04:32:42Z","timestamp":1713328362000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-024-05111-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,17]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5111"],"URL":"https:\/\/doi.org\/10.1186\/s12967-024-05111-z","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,17]]},"assertion":[{"value":"1 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The publication of this article was approved by the Clinical Research Ethics Committee of the Minhang Hospital, Fudan University, Shanghai, China (2021-035-01X).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not Applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have declared that no conflict of interest exists.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"361"}}